METRC Announce Short Term Project Funding

METRC Announce Short Term Project Funding £3000 going to £7000.

Short Term Project Funding is designed to support small research projects to explore the feasibility of innovative new products and processes. In the first stage, funds of up to £3,000 are available to support collaborative projects between METRC’s academic members and industry partners. The funding can be used flexibly at the METRC academic  institutions on a range of activities such as project consumables, paying for researchers or some limited consultancy work. For the most successful projects, funding can be extended into a second stage worth up to an additional £7,000 providing there is a matching contribution from an industrial partner.

he call will open on 16th October 2009 and funding will be available on a first-come first-served basis. We will be accepting applications for stage 2 funding from 1st January 2010 and there is funding available to support up to 10 stage 2 projects. We expect that a second tranche of Short Term Project Funding will be made available during 2010.

The Contacts Are:

Richard France – r.m.france@sheffield.ac.uk, 0114 222 9563
Simon Butler – simon.butler@sheffield.ac.uk, 0114 222 9450
Sam Whitehouse – S.P.Whitehouse@sheffield.ac.uk, 0114 222 9493

If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

ida 100programme 515x64 LowRes METRC Announce Short Term Project Funding

Turn your Business Into an Investor Magnet

How to Write a Business Plan – Free E-Course

Get the secrets that turns your project into an investment magnet, 100% of our clients raise the finance they need to take their projects to the next stage, we will share these secrets with you. – Sign up for Free

Grow your Expertise for Free

As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.

First name

E-mail address

This guideline ap
recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.
ida consultants freestrategyconsultation 515x64 METRC Announce Short Term Project Funding

For Assistance with Regulatory Planning and Exicution of Clinical Trials Click Here


Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.


Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Fill Out the Short Form Below…




Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>